{{Rsnum
|rsid=285
|Gene=LPL
|Chromosome=8
|position=19957678
|Orientation=plus
|GMAF=0.4458
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=LPL
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 30.8 | 35.4 | 33.8
| HCB | 46.7 | 44.4 | 8.9
| JPT | 55.6 | 31.1 | 13.3
| YRI | 0.0 | 1.6 | 98.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 46.7 | 44.4 | 8.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20943490
|Title=[Meta-analysis of LPL Pvu? polymorphism with hyperlipoidemia and coronary heart disease in the Chinese population.]
}}

{{PMID|16965549}} A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology.

{{PMID|18922999}} Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis.

{{PMID|19041386|OA=1
}} Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.

{{PMID|19913121|OA=1
}} Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.

{{PMID|20021678|OA=1
}} Evaluation of self-reported ethnicity in a case-control population: the stroke prevention in young women study.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}